Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
7,006
Value
$4.37M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,006$4.37M<0.1%−1,338−16.0%ReducedHolders
Q1 20268,344$6.45M<0.1%+202+2.5%AddedHolders
Q4 20258,142$6.28M<0.1%+2,202+37.1%AddedHolders
Q3 20255,940$3.34M<0.1%+1,325+28.7%AddedHolders
Q2 20254,615$2.42M<0.1%−1,560−25.3%ReducedHolders
Q1 20256,175$3.92M<0.1%−1,173−16.0%ReducedHolders
Q4 20247,348$5.23M<0.1%−2,141−22.6%ReducedHolders
Q3 20249,489$9.98M<0.1%−97−1.0%ReducedHolders
Q2 20249,586$10.1M<0.1%−154−1.6%ReducedHolders
Q1 20249,740$9.37M<0.1%+129+1.3%AddedHolders
Q4 20239,611$8.44M<0.1%+145+1.5%AddedHolders
Q3 20239,466$7.79M<0.1%−1,179−11.1%ReducedHolders
Q2 202310,645$7.65M<0.1%−5,943−35.8%ReducedHolders
Q1 202316,588$13.6M0.1%+6,294+61.1%AddedHolders
Q4 202210,294$7.43M<0.1%−75−0.7%ReducedHolders
Q3 202210,369$7.14M<0.1%+1,749+20.3%AddedHolders
Q2 20228,620$5.10M<0.1%+4,881+130.5%AddedHolders
Q1 20223,739$2.61M<0.1%+40+1.1%AddedHolders
Q4 20213,699$2.34M<0.1%+130+3.6%AddedHolders
Q3 20213,569$2.16M<0.1%+76+2.2%AddedHolders
Q2 20213,493$1.95M<0.1%−2,990−46.1%ReducedHolders
Q1 20216,483$3.07M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.